Acadian Asset Management
SNOA icon

Acadian Asset Management’s Sonoma Pharmaceuticals SNOA Stock Holding History

Acadian Asset Management’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-262
Closed -$38K – 1992
2021
Q2 		$38K Sell
262
-39
-13% -$6.12K ﹤0.01% 1842
2021
Q1 		$45K Sell
301
-127
-30% -$20.5K ﹤0.01% 1849
2020
Q4 		$62K Hold
428
– – ﹤0.01% 1884
2020
Q3 		$72K Hold
428
– – ﹤0.01% 1757
2020
Q2 		$61K Buy
428
+350
+449% +$42K ﹤0.01% 1864
2020
Q1 		$8K Hold
78
– – ﹤0.01% 1717
2019
Q4 		$6K Hold
78
– – ﹤0.01% 1773
2019
Q3 		$9K Hold
78
– – ﹤0.01% 1775
2019
Q2 		$12K Hold
78
– – ﹤0.01% 1627
2019
Q1 		$14K Hold
78
– – ﹤0.01% 1843
2018
Q4 		$10K Buy
78
+51
+189% +$10.2K ﹤0.01% 1609
2018
Q3 		$7K Hold
27
– – ﹤0.01% 1598
2018
Q2 		$12K Buy
+27
New +$17.6K ﹤0.01% 1567
2017
Q4 		– Sell
-5
Closed -$5K – 1669
2017
Q3 		$5K Sell
5
-12
-71% -$13K ﹤0.01% 1340
2017
Q2 		$20K Buy
17
+16
+1,600% +$19.7K ﹤0.01% 1259
2017
Q1 		$1K Buy
+1
New +$1.16K ﹤0.01% 1528
2016
Q2 		– Sell
-5
Closed -$4K – 1521
2016
Q1 		$4K Buy
+5
New +$4.64K ﹤0.01% 1294

Other funds holding SNOA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Acadian Asset Management's SNOA Position: Q3 2021 in Review

Acadian Asset Management sold out of Sonoma Pharmaceuticals (SNOA) in Q3 2021, closing a stake of 262 shares — an estimated $38K sold.

Acadian Asset Management first reported a position in SNOA in Q1 2016 and held it in 17 quarters. The position peaked at $72K in Q3 2020. 20 funds tracked by Wall St. Rank hold SNOA as of Q3 2021.

  • Acadian Asset Management reported no remaining Sonoma Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Acadian Asset Management sold 262 Sonoma Pharmaceuticals shares in Q3 2021, an estimated $38K.
  • Acadian Asset Management first reported a position in Sonoma Pharmaceuticals in Q1 2016 and held it in 17 quarters.
  • Acadian Asset Management's Sonoma Pharmaceuticals position peaked at $72K in Q3 2020.
  • 20 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q3 2021.

Based on Acadian Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.